Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consumption: A retrospective cohort study

Table 2 Medications in study subjects

	Anagliptin	Linagliptin	P-value
Dosage	100 mg: 47; 200 mg: 70	5 mg	-
Anti-hypertensive agents	42	46	0.59
ARB or ACE inhibitors	31	36	0.47
Cholesterol-lowering agents	41	37	0.58
Insulin	7	8	0.79
Concomitant oral hypoglycemic agents
Metformin	48	42	0.42
Sulfonylureas	44	40	0.59
Glinides	3	4	0.70
α-glucosidase inhibitors	4	6	0.52
Pioglitazone	1	2	0.56
SGLT2 inhibitors	1	0	0.32
No medication	33	37	0.57
Additional medications for hypertension	1	2	0.56
Additional medications for dyslipidemia	3	3	1.00
Additional medications for diabetes	12	16	0.42

ARB: Angiotensin II receptor blocker; ACE: Angiotensin converting enzyme; SGLT2: Sodium-glucose cotransporter 2.